Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Diagnosis and management of autoimmune hepatitis
L Muratori, AW Lohse, M Lenzi - Bmj, 2023 - bmj.com
Autoimmune hepatitis is an inflammatory disease of the liver of unknown cause that may
progress to liver cirrhosis and end stage liver failure if diagnosis is overlooked and treatment …
progress to liver cirrhosis and end stage liver failure if diagnosis is overlooked and treatment …
[HTML][HTML] Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype
increasingly ascribed to drugs is autoimmune-like hepatitis (ALH). This article summarises …
increasingly ascribed to drugs is autoimmune-like hepatitis (ALH). This article summarises …
Autoimmune hepatitis
BT Beretta-Piccoli, G Mieli-Vergani… - The Rose and Mackay …, 2024 - Elsevier
Autoimmune hepatitis (AIH) is an inflammatory liver disease, affecting mainly females,
characterized by elevated transaminase and immunoglobulin G (IgG) levels, interface …
characterized by elevated transaminase and immunoglobulin G (IgG) levels, interface …
[HTML][HTML] An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
RJ Snijders, AEC Stoelinga, TJG Gevers, S Pape… - Journal of …, 2024 - Elsevier
Background & Aims Patients with autoimmune hepatitis (AIH) almost invariably require
lifelong immunosuppressive treatment. There is genuine concern about the efficacy and …
lifelong immunosuppressive treatment. There is genuine concern about the efficacy and …
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
Background and Aims Autoimmune hepatitis (AIH) is a rare chronic liver disease of unknown
aetiology; the risk of hepatocellular carcinoma (HCC) remains unclear and risk factors are …
aetiology; the risk of hepatocellular carcinoma (HCC) remains unclear and risk factors are …
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry
CD Slooter, FF Van Den Brand, A Lleo, F Colapietro… - Hepatology, 2024 - journals.lww.com
Methods: This retrospective, observational, multicenter study included all patients with a
clinical diagnosis of AIH from the IAIHG-RR. The quality assessment consisted of external …
clinical diagnosis of AIH from the IAIHG-RR. The quality assessment consisted of external …
Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood
G Maggiore, O Bernard, A Mosca, E Ballot… - Journal of …, 2023 - Elsevier
Background & Aims In children with autoimmune hepatitis, uncertainties include outcomes
associated with type 2 hepatitis, the possibility of and criteria for attempting withdrawal of …
associated with type 2 hepatitis, the possibility of and criteria for attempting withdrawal of …
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry
M Riveiro‐Barciela, A Barreira‐Díaz… - Liver …, 2024 - Wiley Online Library
Abstract Background and Aims Small series suggest that rituximab could be effective as
treatment for autoimmune hepatitis (AIH), although data are scarce. We aimed to evaluate …
treatment for autoimmune hepatitis (AIH), although data are scarce. We aimed to evaluate …
[HTML][HTML] Autoimmune hepatitis: Current and future therapies
NS Reau, CS Lammert… - Hepatology …, 2024 - journals.lww.com
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease that can lead to cirrhosis
and liver failure. AIH can present in all ages, races, and ethnicities, but it predominantly …
and liver failure. AIH can present in all ages, races, and ethnicities, but it predominantly …
Therapeutic modulation of the liver immune microenvironment
Inflammation is a hallmark of progressive liver diseases such as chronic viral or immune-
mediated hepatitis, alcohol-associated liver disease, and NAFLD. Preclinical and clinical …
mediated hepatitis, alcohol-associated liver disease, and NAFLD. Preclinical and clinical …